NCT01468974 - ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions

AtherosclerosisPeripheral Vascular DiseaseClaudication

Interventions

DEVICE

ESPRIT BVS

Subjects receiving ESPRIT BVS for the treatment of symptomatic claudication from occlusive vascular disease of the superficial femoral (SFA) or common or external iliac arteries

Trial Locations (8)

Unknown

Medical University of Vienna, Vienna

Sint-Blasius Hospital, Dendermonde

Oost Limburg Ziekenhuis, Genk

Gent University Hospital, Ghent

Clinique Pasteur, Toulouse

Herzzentrum Bad Krozingen, Bad Krozingen

Park-Krankenhaus Leipzig, Leipzig

0886.537.933

Abbott Vascular International BVBA, Brussels